Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY

Transcatheter tricuspid valve intervention, whether surgical or transcatheter-based, was associated with improved survival in patients with pEF but not in those with mrEF or rEF. Residual TR remained a significant prognostic factor across the entire LVEF spectrum. These findings highlight the need for careful patient selection when considering TTVI in individuals with rEF.

Authors

Institutions

Publication Details

Journal
European Journal of Heart Failure
Published
2025-08-30
DOI
https://doi.org/10.1002/ejhf.3797
Citations
3
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
4.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY

Elisabeth Riant, Maurice L. Enriquez-Sarano, Jean‐François Obadia, Christos Iliadis et al.
3 citations
European Journal of Heart Failure
Cardiac Valve Diseases and Treatments
4.16
article

Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY

Elisabeth Riant, Maurice L. Enriquez-Sarano, Jean‐François Obadia, Christos Iliadis, Yan Topilsky, Andrea Eixerés‐Esteve, Volker Rudolph, Vincent Chan, Philipp Emanuel Bartko, Jordan Bernick, Julien Dreyfus, Giovanni Benfari, Bernard Iung, Yohann Bohbot, Rodrigo Estévez‐Loureiro, Giulio Russo, Baptiste Bazire, George A. Wells, Luigi Paolo Badano, Gregor Heitzinger, Juan A. Crestanello, Thomas Modine, Samuel Heuts, Denisa Muraru, Marcel Weber, Varius Dannenberg, Jörg Hausleiter, Rebecca Tung Hahn, Ralph Stephan von Bardeleben, David Messika‐Zeitoun, Michele De Bonis, Nina Ajmone Marsan, Maurizio Taramasso, Lukas Stolz, Yoan Lavie‐Badie, Manuel Carnero, Marianna Adamo, Luis Nombela-Franco y, Erwan Donal, Fabien Praz, Neil Fam, Augustin Coisne, José Luis Zamorano, Mohammed Nejjari, Thierry Le Tourneau, Jeroen J. Bax, Roja Gauda, Horst Sievert, Francesco Maisano, G. Habib, Philipp Lurz
article en
3 citations

Abstract

Transcatheter tricuspid valve intervention, whether surgical or transcatheter-based, was associated with improved survival in patients with pEF but not in those with mrEF or rEF. Residual TR remained a significant prognostic factor across the entire LVEF spectrum. These findings highlight the need for careful patient selection when considering TTVI in individuals with rEF.

European Journal of Heart FailureVol. 27(11)
Université Claude Bernard Lyon 1 (FR), University of Bern (CH), University of Verona (IT), Centre National de la Recherche Scientifique (FR), St. Michael's Hospital (CA), Valve (United States) (US), Mayo Clinic (US), NewYork–Presbyterian Hospital (US), University of Ottawa (CA), Vita-Salute San Raffaele University (IT), Inserm (FR), Tel Aviv University (IL), Johannes Gutenberg University Mainz (DE), Instituto Cajal (ES), Université de Lille (FR), University Hospital Bonn (DE), Columbia University Irving Medical Center (US), University Hospitals of the Ruhr-University of Bochum (DE), Leiden University Medical Center (NL), Polyclinic Medical Center (US), Maastricht University Medical Centre (NL), Heart and Diabetes Center North Rhine-Westphalia (DE), Institut Pasteur de Lille (FR), New York Hospital Queens (US), University Hospital of Bern (CH), University Hospital Complex Of Vigo (ES), Hospital Clínico San Carlos (ES), Centre Hospitalier Universitaire de Lille (FR), Maastricht University (NL), Research Institute Hospital 12 de Octubre (ES), University Medical Center of the Johannes Gutenberg University Mainz (DE), Centre Hospitalier Universitaire Amiens-Picardie (FR), Assistance Publique – Hôpitaux de Paris (FR), Surgical Specialties (Canada) (CA), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Hôpital Cardiologique du Haut-Lévêque (FR), München Klinik (DE), Mayo Clinic in Arizona (US), Cardiovascular Center Frankfurt (DE), St Michael's Hospital (GB), IRCCS Ospedale San Raffaele (IT), Minneapolis Heart Institute Foundation (US), Laboratoire de Recherche Vasculaire Translationnelle (FR), IRCCS Istituto Auxologico Italiano (IT), Hôpital Louis Pradel (FR), Policlinico Tor Vergata (IT), Institut du Thorax (FR), Mayo Clinic in Florida (US), St Michael's Hospital (GB), GastroZentrum Hirslanden Zürich (CH), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University Hospital Cologne (DE), Centre Cardiologique du Nord (FR), Hospital Universitario Ramón y Cajal (ES), Hôpital de la Timone (FR), Université de Picardie Jules Verne (FR), Université de Rennes (FR), University of Milano-Bicocca (IT), Medical University of Vienna (AT), University of Brescia (IT)
Openalex Percentile: Top 5%
Cardiac Valve Diseases and Treatments
4.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.